Primary study · included by 1 review

Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.

Grewal 2009 · Grewal Ravinder K, Larson Steven M, Pentlow Christina E, et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2009

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.

Non-Cochrane · prognostic · 2026 · cited as Grewal 2009 · Supplementary Table S3 (included studies); Figs. 1-3

Outcome this study informs	Pooled effect	Evidence	Certainty
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · more than 1 year after RIT	Prevalence 0.17 [0.10, 0.28]	6 studies · 1005 participants	GRADE not reported

1 including review in total.